• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于器官型乳腺导管模型的方法,用于研究基质力学依赖性导管癌进展。

An Organotypic Mammary Duct Model Capturing Matrix Mechanics-Dependent Ductal Carcinoma Progression.

机构信息

Department of Biomedical Engineering, Aerospace, and Nuclear Engineering, Rensselaer Polytechnic Institute, Troy, New York, USA.

Center for Biotechnology and Interdisciplinary Studies, Aerospace, and Nuclear Engineering, Rensselaer Polytechnic Institute, Troy, New York, USA.

出版信息

Tissue Eng Part A. 2021 Apr;27(7-8):454-466. doi: 10.1089/ten.TEA.2020.0239. Epub 2021 Mar 1.

DOI:10.1089/ten.TEA.2020.0239
PMID:33397202
Abstract

Ductal carcinoma (DCIS) is a precancerous stage breast cancer, where abnormal cells are contained within the duct, but have not invaded into the surrounding tissue. However, only 30-40% of DCIS cases are likely to progress into an invasive ductal carcinoma (IDC), while the remainder are innocuous. Since little is known about what contributes to the transition from DCIS to IDC, clinicians and patients tend to opt for treatment, leading to concerns of overdiagnosis and overtreatment. models are currently being used to probe how DCIS transitions into IDC, but many models do not take into consideration the macroscopic tissue architecture and the biomechanical properties of the microenvironment. In this study, we modeled an organotypic mammary duct as a channel molded in a collagen matrix and lined with basement membrane. By adjusting the concentration of collagen (4 and 8 mg/mL), we modulated the stiffness and morphological properties of the matrix and examined how an assortment of breast cells, including the isogenic MCF10 series that spans the range from healthy to aggressive, behaved within our model. We observed distinct characteristics of breast cancer progression such as hyperplasia and invasion. Normal mammary epithelial cells (MCF10A) formed a single-cell layer on the lumen surface, whereas the most aggressive (MCF10CA1) were several cell layers thick. The model captured collagen concentration-dependent protrusive behaviors by the MCF10A and MCF10CA1 cells, as well as a known invasive cell line (MDA-MB-231). The MCF10A and MCF10CA1 cells extended protrusions into the lower collagen concentration matrix, while the MDA-MB-231 cells fully invaded matrices of either collagen concentration but to a greater distance in the higher collagen concentration matrix. Our results show that the model can recapitulate different stages of breast cancer progression and that the MCF10 series is adaptable to physiologically relevant studies, demonstrating the potential of both the model and cell lines to elucidate key factors that may contribute to understanding the transition from DCIS to IDC. Impact statement The success of early preventative measures for breast cancer has left patients susceptible to overdiagnosis and overtreatment. Limited knowledge of factors driving an invasive transition has inspired the development of models that accurately capture this phenomenon. However, current models tend to neglect the macroscopic architecture and biomechanical properties of the mammary duct. In this study, we introduce an organotypic model that recapitulates the cylindrical geometry of the tissue and the altered stroma seen in tumor microenvironments. Our model was able to capture distinct features associated with breast cancer progression, demonstrating its potential to uncover novel insights into disease progression.

摘要

导管癌(DCIS)是一种癌前乳腺癌,异常细胞位于导管内,但尚未侵犯周围组织。然而,只有 30-40%的 DCIS 病例可能进展为浸润性导管癌(IDC),其余的则是无害的。由于人们对导致 DCIS 向 IDC 转化的因素知之甚少,临床医生和患者往往选择治疗,导致过度诊断和过度治疗的担忧。目前正在使用模型来探究 DCIS 如何向 IDC 转化,但许多模型没有考虑到宏观组织架构和微环境的生物力学特性。在这项研究中,我们将器官型乳腺导管建模为一个模制在胶原基质中的通道,并由基底膜衬里。通过调整胶原浓度(4 和 8mg/mL),我们调节了基质的硬度和形态特性,并研究了一系列乳腺细胞,包括跨越健康到侵袭性范围的同基因 MCF10 系列,在我们的模型中的行为。我们观察到了乳腺癌进展的明显特征,如增生和浸润。正常乳腺上皮细胞(MCF10A)在腔表面形成单层细胞,而最具侵袭性的(MCF10CA1)则有几层细胞厚。该模型捕捉到了 MCF10A 和 MCF10CA1 细胞以及已知侵袭性细胞系(MDA-MB-231)对胶原浓度的依赖的突起行为。MCF10A 和 MCF10CA1 细胞将突起延伸到较低胶原浓度的基质中,而 MDA-MB-231 细胞则完全侵入两种胶原浓度的基质,但在较高胶原浓度的基质中侵入的距离更大。我们的结果表明,该模型可以再现乳腺癌进展的不同阶段,而 MCF10 系列适应于生理相关的研究,这表明该模型和细胞系都有潜力阐明可能有助于理解从 DCIS 向 IDC 转化的关键因素。

影响说明

早期预防性乳腺癌措施的成功使患者容易受到过度诊断和过度治疗的影响。对驱动侵袭性转变的因素的了解有限,激发了开发能够准确捕捉这一现象的模型的发展。然而,目前的模型往往忽略了乳腺导管的宏观结构和生物力学特性。在这项研究中,我们引入了一种器官型模型,该模型再现了组织的圆柱形几何形状和肿瘤微环境中可见的改变的基质。我们的模型能够捕捉到与乳腺癌进展相关的独特特征,表明其有潜力揭示疾病进展的新见解。

相似文献

1
An Organotypic Mammary Duct Model Capturing Matrix Mechanics-Dependent Ductal Carcinoma Progression.一种基于器官型乳腺导管模型的方法,用于研究基质力学依赖性导管癌进展。
Tissue Eng Part A. 2021 Apr;27(7-8):454-466. doi: 10.1089/ten.TEA.2020.0239. Epub 2021 Mar 1.
2
Microfluidic model of ductal carcinoma in situ with 3D, organotypic structure.具有三维器官样结构的原位导管癌微流控模型
BMC Cancer. 2015 Jan 21;15:12. doi: 10.1186/s12885-015-1007-5.
3
Breast cancer subtype-specific interactions with the microenvironment dictate mechanisms of invasion.乳腺癌亚型与微环境的特异性相互作用决定了浸润的机制。
Cancer Res. 2011 Nov 1;71(21):6857-66. doi: 10.1158/0008-5472.CAN-11-1818. Epub 2011 Sep 9.
4
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.肿瘤上皮和基质成分在乳腺癌进展过程中的基因表达谱分析。
Breast Cancer Res Treat. 2012 Aug;135(1):153-65. doi: 10.1007/s10549-012-2123-4. Epub 2012 Jun 21.
5
Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.沉默 MCF10DCIS.com 细胞中的 HSulf-2 表达可减弱体内导管原位癌向浸润性导管癌的进展。
Breast Cancer Res. 2012 Mar 12;14(2):R43. doi: 10.1186/bcr3140.
6
In Vitro Models for Studying Invasive Transitions of Ductal Carcinoma In Situ.用于研究导管原位癌侵袭性转移的体外模型。
J Mammary Gland Biol Neoplasia. 2019 Mar;24(1):1-15. doi: 10.1007/s10911-018-9405-3. Epub 2018 Jul 28.
7
Everolimus Inhibits the Progression of Ductal Carcinoma to Invasive Breast Cancer Via Downregulation of MMP9 Expression.依维莫司通过下调 MMP9 表达抑制导管癌进展为浸润性乳腺癌。
Clin Cancer Res. 2020 Mar 15;26(6):1486-1496. doi: 10.1158/1078-0432.CCR-19-2478. Epub 2019 Dec 23.
8
Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.乳腺癌基质和上皮细胞中的并发及独立基因改变:对肿瘤发生的影响
Cancer Res. 2000 May 1;60(9):2562-6.
9
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis.糖皮质激素通过诱导肌上皮细胞凋亡促进导管原位癌向浸润性导管癌的转化。
Breast Cancer Res. 2018 Jul 4;20(1):65. doi: 10.1186/s13058-018-0977-z.
10
Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.体内导管原位癌进展模型的表达谱分析确定B细胞淋巴瘤-9是乳腺癌侵袭的分子驱动因素。
Breast Cancer Res. 2015 Sep 17;17:128. doi: 10.1186/s13058-015-0630-z.

引用本文的文献

1
Three-Dimensional Models: Biomimetic Tools That Recapitulate Breast Tissue Architecture and Microenvironment to Study Ductal Carcinoma In Situ Transition to Invasive Ductal Breast Cancer.三维模型:模拟乳腺组织结构和微环境以研究导管原位癌向浸润性导管癌转变的仿生工具。
Cells. 2025 Feb 4;14(3):220. doi: 10.3390/cells14030220.
2
Long Prehensile Protrusions Can Facilitate Cancer Cell Invasion through the Basement Membrane.长的可伸缩突起可促进癌细胞穿透基底膜的侵袭。
Cells. 2023 Oct 18;12(20):2474. doi: 10.3390/cells12202474.
3
Identifying recurrences and metastasis after ductal carcinoma in situ (DCIS) of the breast.
乳腺癌导管原位癌(DCIS)术后复发和转移的检测。
Histopathology. 2023 Jan;82(1):106-118. doi: 10.1111/his.14804.
4
Diversity Models and Applications of 3D Breast Tumor-on-a-Chip.三维乳腺芯片肿瘤的多样性模型与应用
Micromachines (Basel). 2021 Jul 12;12(7):814. doi: 10.3390/mi12070814.